BESNER; Gail E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for BESNER; Gail E..The latest application filed is for "prebiotic formulations for prevention of sepsis and necroenterocolitis induced neurodevelopmental deficiencies".

Company Profile

1.5.18

BESNER; Gail E. - Columbus OH
Besner; Gail E. - Dublin OH
Besner; Gail E. - Buffalo NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Prebiotic Formulations For Prevention Of Sepsis And Necroenterocolitis Induced Neurodevelopmental Deficiencies App 20210401904 - BESNER; Gail E. ; et al.	2021-12-30
Tissue Engineered Intestine App 20210030924 - Besner; Gail E. ; et al.	2021-02-04
Methods Of Delivering Heparin Binding Epidermal Growth Factor Using Stem Cell Generated Exosomes App 20200405812 - Besner; Gail E. ; et al.	2020-12-31
Methods Of Delivering Heparin Binding Epidermal Growth Factor Using Stem Cell Generated Exosomes App 20170173113 - Besner; Gail E. ; et al.	2017-06-22
Tissue Engineered Intestine App 20160022873 - BESNER; Gail E. ; et al.	2016-01-28
Heparin binding epidermal growth factor (HB-EGF) for use in methods of treating and preventing intestinal injury related to hemorrhagic shock and resuscitation Grant 9,060,977 - Besner , et al. June 23, 2	2015-06-23
Methods of Treating Necrotizing Enterocolitis Using Heparin Binding Epidermal Growth Factor App 20130244935 - Besner; Gail E.	2013-09-19
Methods of Treating Intestinal Injury Using Heparin Binding Epidermal Growth Factor and Stem Cells App 20130216502 - Besner; Gail E.	2013-08-22
Heparin Binding Epidermal Growth Factor (HB-EGF) for Use in Methods of Treating and Preventing Intestinal Injury Related to Hemorrhagic Shock and Resuscitation App 20130165376 - Besner; Gail E. ; et al.	2013-06-27
Administration Of Heparin Binding Epidermal Growth Factor For The Protection Of Enteric Neurons App 20130130984 - Besner; Gail E.	2013-05-23
Administration of HB-EGF for the Protection of Enteric Neurons App 20120053121 - BESNER; GAIL E. ; et al.	2012-03-01
Heparin binding epidermal growth factor (HB-EGF) for use in methods of treating and preventing intestinal injury related to hemorrhagic shock and resuscitation Grant 8,093,213 - Besner , et al. January 10, 2	2012-01-10
Methods Of Treating Necrotizing Enterocolitis Using Heparin Binding Epidermal Growth Factor (hb-egf) App 20110275566 - Besner; Gail E.	2011-11-10
Heparin Binding Epidermal Growth Factor (hb-egf) For Use In Methods Of Treating And Preventing Intestinal Injury Related To Hemorrhagic Shock And Resuscitation App 20100222265 - Besner; Gail E. ; et al.	2010-09-02
Methods of treating intestinal ischemia using heparin-binding epidermal growth factor Grant 7,276,479 - Besner , et al. October 2, 2	2007-10-02
Methods of treating intestinal ischemia using heparin-binding epidermal growth factor App 20060019898 - Besner; Gail E. ; et al.	2006-01-26
Methods of treating intestinal ischemia using heparin-binding epidermal growth factor App 20030166564 - Besner, Gail E. ; et al.	2003-09-04
Methods of treating intestinal ischemia using heparin-binding epidermal growth factor App 20030027758 - Besner, Gail E. ; et al.	2003-02-06
Heparin binding mitogen with homology to epidermal growth factor (EGF) Grant 5,811,393 - Klagsbrun , et al. September 22, 1	1998-09-22

Company Registrations

NCAGE Code	432F4	BESNER GAIL E
CAGE Code	432F4	BESNER, GAIL E
DUNS	602931607	BESNER, GAIL E

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.